Results 271 to 280 of about 14,786 (290)

Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy

Angewandte Chemie - International Edition, 2023
Yan-Feng Gao, Hai Wang
exaly  

Current advances and development strategies of orally bioavailable PROTACs

European Journal of Medicinal Chemistry, 2023
shenxin zeng
exaly  

Developments of CRBN-based PROTACs as potential therapeutic agents

European Journal of Medicinal Chemistry, 2021
Yudong Wu, Dong-Ming Xing
exaly  

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones

SLAS Discovery, 2021
Tasuku Ishida, Alessio Ciulli
exaly  

Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation

Nature Structural & Molecular Biology
Yanran Li, Kaiwen Bao, Jiyue Sun, Ruixin Ge, Qiqing Zhang, Bing-Quan Zhang, Xiaojie Yan, Junlin Li, Fengying Shi, Meiling Zhang, Jinzhi Zang, Min Liu, Jun Zhou, Wenyi Mi, Songbo Xie, Dongxing Chen, Lei Shi, Cheng Dong   +17 more
semanticscholar   +1 more source

PROTACs: An Emerging Therapeutic Modality in Precision Medicine

Cell Chemical Biology, 2020
Dhanusha A Nalawansha, Craig M Crews
exaly  

Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery

Bioorganic Chemistry, 2022
Lin Yao, Ru Jiang, Li Fan
exaly  

PROTACs: Promising approach for anticancer therapy

Cancer Letters, 2023
Deepak N Kapoor
exaly  

VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives

European Journal of Medicinal Chemistry, 2022
Dong-Ming Xing
exaly  

EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex

Cell Chemical Biology, 2020
Jessie Hao-Ru Hsu, James Robinson, Fiona Pachl   +2 more
exaly